Income Statement Zenotech Laboratories Limited

Stocks

ZENOTECH6

INE486F01012

Pharmaceuticals

Market Closed - Bombay S.E. 06:02:28 2026-09-18 EDT			5-day change	1st Jan Change
44.24 ^INR	-1.69%		-1.65%	-4.22%

07-28	Zenotech Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
04-29	Zenotech Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI

be7b.4_EhsYk70u01Y2KSD48LeBXpbgJUxZ80W9RnvKPHlCw.u4dM_8xKmoRFJxCjOtdODCzEA3ASiOlXE6cj7daz1X6uhgyA81G-j1EWEQ

Published financial data: ZENOTECH LABORATORIES LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)	2026 (INR)
Revenues	325M	384M	368M	390M	396M
Other Revenues, Total	4.53M	6.56M	474K	1.23M	6.01M
Total Revenues	329M	390M	368M	391M	402M
Cost of Goods Sold, Total	30.48M	29.34M	30.89M	43.24M	35.48M
Gross Profit	299M	361M	337M	348M	366M
Selling General & Admin Expenses, Total	71.18M	78.99M	94.82M	124M	156M
Depreciation & Amortization - (IS)	69.74M	71.73M	70.85M	69.6M	71.13M
Other Operating Expenses	48.64M	68.15M	69.73M	80.54M	112M
Other Operating Expenses, Total	190M	219M	235M	274M	339M
Operating Income	109M	142M	102M	73.6M	27.56M
Interest Expense, Total	-12.15M	-1.12M	-	-	-
Interest And Investment Income	986K	3.68M	9.45M	14.09M	16.65M
Net Interest Expenses	-11.17M	2.56M	9.45M	14.09M	16.65M
Currency Exchange Gains (Loss)	-27K	-6K	54K	-177K	-792K
Other Non Operating Income (Expenses)	-	-	-	-	-
EBT, Excl. Unusual Items	98.23M	144M	111M	87.52M	43.41M
Gain (Loss) On Sale Of Assets	-	388K	-	-	-
Asset Writedown	-	-	-	-	-
Legal Settlements	-	-	-	-	-
Other Unusual Items	779K	200K	116K	19.4M	-1.52M
EBT, Incl. Unusual Items	99.01M	145M	111M	107M	41.89M
Income Tax Expense	-123M	29.17M	28.43M	50.79M	52.61M
Earnings From Continuing Operations	222M	116M	82.99M	56.13M	-10.72M
Net Income to Company	222M	116M	82.99M	56.13M	-10.72M
Net Income - (IS)	222M	116M	82.99M	56.13M	-10.72M
Net Income to Common Incl Extra Items	222M	116M	82.99M	56.13M	-10.72M
Net Income to Common Excl. Extra Items	222M	116M	82.99M	56.13M	-10.72M
Per Share Items
Net EPS - Basic	3.63	1.9	1.36	0.92	-0.18
Basic EPS - Continuing Operations	3.63	1.9	1.36	0.92	-0.18
Basic Weighted Average Shares Outstanding	61.03M	61.03M	61.03M	61.03M	61.03M
Net EPS - Diluted	3.63	1.9	1.36	0.92	-0.18
Diluted EPS - Continuing Operations	3.63	1.9	1.36	0.92	-0.18
Diluted Weighted Average Shares Outstanding	61.03M	61.03M	61.03M	61.03M	61.03M
Normalized Basic EPS	1.01	1.48	1.14	0.9	0.44
Normalized Diluted EPS	1.01	1.48	1.14	0.9	0.44
Supplemental Items
EBITDA	179M	214M	173M	143M	98.69M
EBITA	109M	142M	102M	73.6M	27.56M
EBIT	109M	142M	102M	73.6M	27.56M
Total Revenues (As Reported)	372M	435M	418M	446M	459M
Effective Tax Rate - (Ratio)	-123.97	20.11	25.51	47.5	125.59
Total Current Taxes	-	-	-	19.05M	-
Total Deferred Taxes	-123M	29.17M	28.43M	25.86M	47.72M
Normalized Net Income	61.4M	90.27M	69.56M	54.7M	27.13M
Interest Capitalized	-	-	-	-	-
Interest on Long-Term Debt	-	-	-	-	-
Non-Cash Pension Expense	264K	337K	412K	470K	596K
Supplemental Operating Expense Items
Advertising Expense	229K	231K	182K	218K	221K
Selling and Marketing Expenses	229K	231K	182K	218K	221K
Maintenance & Repair Expenses, Total	30.47M	28.74M	30.89M	34.84M	35.48M

Fiscal Period: March	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)	2026 (INR)
Assets
Cash And Equivalents	24.15M	111M	197M	267M	304M
Short Term Investments	-	-	20K	20K	-
Total Cash And Short Term Investments	24.15M	111M	197M	267M	304M
Accounts Receivable, Total	39.28M	33.24M	32.49M	74.54M	89.66M
Other Receivables	1.58M	6.76M	15.32M	11.05M	11.41M
Total Receivables	40.86M	39.99M	47.82M	85.6M	101M
Inventory	1.35M	239K	8.6M	908K	728K
Prepaid Expenses	3.84M	2.98M	1.39M	2.04M	1.81M
Other Current Assets, Total	3.56M	8.01M	6.94M	4.3M	2.54M
Total Current Assets	73.75M	163M	262M	360M	410M
Gross Property Plant And Equipment	1.05B	1.12B	1.16B	1.2B	1.28B
Accumulated Depreciation	-342M	-414M	-485M	-554M	-625M
Net Property Plant And Equipment	712M	704M	675M	644M	659M
Long-term Investments	-	-	-	-	-
Deferred Tax Assets Long-Term	123M	93.58M	65.26M	39.4M	-
Other Long-Term Assets, Total	32.46M	48.87M	59.8M	66.6M	42.21M
Total Assets	941M	1.01B	1.06B	1.11B	1.11B
Liabilities
Accounts Payable, Total	20.66M	34.77M	28.06M	25.24M	36.96M
Accrued Expenses, Total	130M	126M	102M	83.32M	75.65M
Short-term Borrowings	-	-	-	-	-
Current Portion of Long-Term Debt	-	-	-	-	-
Current Income Taxes Payable	-	-	-	12.15M	-
Unearned Revenue Current, Total	5.11M	5.11M	5.11M	5.11M	5.11M
Other Current Liabilities	-	16K	50K	50K	2.84M
Total Current Liabilities	156M	166M	135M	126M	121M
Long-Term Debt	60M	-	-	-	-
Unearned Revenue Non Current	3.21M	2.46M	9.7M	9.74M	188K
Pension & Other Post Retirement Benefits	4.52M	5.26M	6.16M	7.09M	12.15M
Deferred Tax Liability Non Current	-	-	-	-	8.31M
Other Non Current Liabilities	10.95M	12.24M	5.55M	6.3M	19.1M
Total Liabilities	234M	186M	157M	149M	160M
Common Stock, Total	610M	610M	610M	610M	610M
Additional Paid In Capital	2.1B	2.1B	2.1B	2.1B	2.1B
Retained Earnings	-2B	-1.88B	-1.8B	-1.74B	-1.75B
Total Common Equity	706M	823M	905M	961M	951M
Total Equity	706M	823M	905M	961M	951M
Total Liabilities And Equity	941M	1.01B	1.06B	1.11B	1.11B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	61.03M	61.03M	61.03M	61.03M	61.03M
ECS Total Common Shares Outstanding	61.03M	61.03M	61.03M	61.03M	61.03M
Book Value / Share	11.57	13.48	14.84	15.75	15.59
Tangible Book Value	706M	823M	905M	961M	951M
Tangible Book Value Per Share	11.57	13.48	14.84	15.75	15.59
Total Debt	60M	0	0	0	0
Net Debt	35.85M	-111M	-197M	-267M	-304M
Debt Equivalent of Unfunded Proj. Benefit Obligation	5.02M	5.79M	6.9M	7.34M	12.54M
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	608K	-	8.4M	-	-
Inventories - Work In Process, Total	-	-	-	-	-
Land - (BS)	10.83M	10.83M	10.83M	10.83M	10.83M
Buildings, Total	212M	212M	212M	213M	224M
Machinery, Total	828M	845M	918M	940M	1.01B
Full Time Employees	137	150	208	228	264
Accumulated Allowance for Doubtful Accounts (Supple)	-	-	-	-	-

Fiscal Period: March	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)	2026 (INR)
Net Income	222M	116M	82.99M	56.13M	-10.72M
Depreciation & Amortization - CF	69.74M	71.73M	70.85M	69.6M	71.13M
Depreciation & Amortization, Total	69.74M	71.73M	70.85M	69.6M	71.13M
(Gain) Loss From Sale Of Asset	-	-388K	437K	-	-
Asset Writedown & Restructuring Costs	-	-	-	-	-
Other Operating Activities, Total	-122M	14.51M	8.08M	-1.91M	43.28M
Change In Accounts Receivable	-1.25M	6.05M	741K	-42.05M	-13.22M
Change In Inventories	11K	608K	-8.4M	8.4M	-
Change In Accounts Payable	2.22M	14.31M	-6.6M	-7.51M	12.16M
Change in Other Net Operating Assets	6.57M	-16.02M	-29.87M	12.22M	-570K
Cash from Operations	177M	207M	118M	94.88M	102M
Capital Expenditure	-19.38M	-62.32M	-42.34M	-38.63M	-83.22M
Sale of Property, Plant, and Equipment	-	388K	37K	-	-
Investment in Marketable and Equity Securities, Total	-	-	-	177M	-78K
Other Investing Activities, Total	986K	3.68M	-169M	14.09M	18.4M
Cash from Investing	-18.39M	-58.24M	-212M	153M	-64.91M
Short Term Debt Issued, Total	-	-	-	-	-
Long-Term Debt Issued, Total	-	-	-	-	-
Total Debt Issued	-	-	-	-	-
Short Term Debt Repaid, Total	-	-	-	-	-
Long-Term Debt Repaid, Total	-147M	-60M	-	-	-
Total Debt Repaid	-147M	-60M	-	-	-
Issuance of Common Stock	-	-	-	-	-
Other Financing Activities, Total	-12.15M	-1.12M	-	-	-
Cash from Financing	-159M	-61.12M	-	-	-
Foreign Exchange Rate Adjustments	-	-	54K	-177K	-
Miscellaneous Cash Flow Adjustments	-	-	-	-	-
Net Change in Cash	-429K	87.28M	-93.27M	248M	37.14M
Supplemental Items
Cash Interest Paid	12.15M	1.12M	-	-	-
Cash Income Tax Paid (Refund)	10.04M	11.9M	10.73M	19.39M	-5.79M
Levered Free Cash Flow	117M	106M	47.77M	39.51M	-13.54M
Unlevered Free Cash Flow	124M	107M	47.77M	39.51M	-13.54M
Change In Net Working Capital	-5.57M	-8.69M	44.37M	37.46M	18.67M
Net Debt Issued / Repaid	-147M	-60M	-	-	-

Fiscal Period: March	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)	2026 (INR)
Profitability
Return on Assets	7.6	9.1	6.14	4.24	1.55
Return on Total Capital	9.39	11.16	7.36	4.93	1.8
Return On Equity %	37.26	15.15	9.6	6.01	-1.12
Return on Common Equity	37.26	15.15	9.6	6.01	-1.12
Margin Analysis
Gross Profit Margin %	90.75	92.48	91.61	88.94	91.17
SG&A Margin	21.6	20.25	25.76	31.71	38.72
EBITDA Margin %	54.38	54.76	46.9	36.63	24.57
EBITA Margin %	33.21	36.37	27.65	18.83	6.86
EBIT Margin %	33.21	36.37	27.65	18.83	6.86
Income From Continuing Operations Margin %	67.31	29.7	22.55	14.36	-2.67
Net Income Margin %	67.31	29.7	22.55	14.36	-2.67
Net Avail. For Common Margin %	67.31	29.7	22.55	14.36	-2.67
Normalized Net Income Margin	18.64	23.14	18.9	13.99	6.76
Levered Free Cash Flow Margin	35.43	27.19	12.98	10.11	-3.37
Unlevered Free Cash Flow Margin	37.73	27.37	12.98	10.11	-3.37
Asset Turnover
Asset Turnover	0.37	0.4	0.36	0.36	0.36
Fixed Assets Turnover	0.45	0.55	0.53	0.59	0.62
Receivables Turnover (Average Receivables)	8.41	10.58	11.19	7.28	4.82
Inventory Turnover (Average Inventory)	27.6	37	6.99	9.1	43.38
Short Term Liquidity
Current Ratio	0.47	0.98	1.93	2.86	3.4
Quick Ratio	0.42	0.91	1.81	2.8	3.36
Operating Cash Flow to Current Liabilities	1.13	1.24	0.87	0.75	0.85
Days Sales Outstanding (Average Receivables)	43.42	34.51	32.72	50.12	75.75
Days Outstanding Inventory (Average Inventory)	13.23	9.86	52.34	40.12	8.41
Average Days Payable Outstanding	235.04	358.27	292.92	298.56	321.54
Cash Conversion Cycle (Average Days)	-178.39	-313.89	-207.85	-208.32	-237.38
Long Term Solvency
Total Debt/Equity	8.49	-	-	-	-
Total Debt / Total Capital	7.83	-	-	-	-
LT Debt/Equity	8.49	-	-	-	-
Long-Term Debt / Total Capital	7.83	-	-	-	-
Total Liabilities / Total Assets	24.92	18.44	14.75	13.42	14.42
EBIT / Interest Expense	9	126.45	-	-	-
EBITDA / Interest Expense	14.74	190.38	-	-	-
(EBITDA - Capex) / Interest Expense	13.15	134.84	-	-	-
Total Debt / EBITDA	0.33	-	-	-	-
Net Debt / EBITDA	0.2	-0.52	-1.14	-1.86	-3.08
Total Debt / (EBITDA - Capex)	0.38	-	-	-	-
Net Debt / (EBITDA - Capex)	0.22	-0.74	-1.51	-2.55	-19.67
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	69.51	18.4	-5.64	6.22	2.72
Gross Profit, 1 Yr. Growth %	66.46	20.66	-6.53	3.13	5.29
EBITDA, 1 Yr. Growth %	178.07	19.22	-19.18	-17.26	-31.08
EBITA, 1 Yr. Growth %	-84.27K	29.66	-28.25	-28	-62.56
EBIT, 1 Yr. Growth %	-84.27K	29.66	-28.25	-28	-62.56
Earnings From Cont. Operations, 1 Yr. Growth %	-1.93K	-47.76	-28.37	-32.36	-119.1
Net Income, 1 Yr. Growth %	-1.93K	-47.76	-28.37	-32.36	-119.1
Normalized Net Income, 1 Yr. Growth %	-752.37	47.03	-22.94	-21.67	-50.39
Diluted EPS Before Extra, 1 Yr. Growth %	-1.92K	-47.71	-28.37	-32.36	-119.57
Accounts Receivable, 1 Yr. Growth %	3.29	-15.39	-2.23	129.41	20.28
Inventory, 1 Yr. Growth %	56.26	-82.26	3.5K	-89.44	-19.82
Net Property, Plant and Equip., 1 Yr. Growth %	-6.84	-1.16	-4.02	-4.59	2.25
Total Assets, 1 Yr. Growth %	9.6	7.22	5.29	4.54	0.28
Tangible Book Value, 1 Yr. Growth %	45.93	16.46	10.05	6.17	-1.05
Common Equity, 1 Yr. Growth %	45.93	16.46	10.05	6.17	-1.05
Cash From Operations, 1 Yr. Growth %	207.74	16.96	-42.79	-19.74	6.91
Capital Expenditures, 1 Yr. Growth %	-60.55	221.64	-32.07	-8.75	112.32
Levered Free Cash Flow, 1 Yr. Growth %	-864.44	-9.12	-54.96	-17.76	-134.7
Unlevered Free Cash Flow, 1 Yr. Growth %	-2.32K	-14.11	-55.26	-17.76	-134.7
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	12.7	41.67	5.7	0.11	4.46
Gross Profit, 2 Yr. CAGR %	8.42	41.72	6.2	-1.82	4.2
EBITDA, 2 Yr. CAGR %	41.25	82.08	-1.84	-18.12	-24.49
EBITA, 2 Yr. CAGR %	62.77	3.2K	-3.55	-27.97	-48.08
EBIT, 2 Yr. CAGR %	62.77	3.2K	-3.55	-27.97	-48.08
Earnings From Cont. Operations, 2 Yr. CAGR %	43.44	208.78	-38.83	-30.4	-64.06
Net Income, 2 Yr. CAGR %	43.44	208.78	-38.83	-30.4	-64.06
Normalized Net Income, 2 Yr. CAGR %	51.27	209.71	6.44	-22.16	-37.67
Diluted EPS Before Extra, 2 Yr. CAGR %	43.37	208.08	-38.8	-30.4	-63.62
Accounts Receivable, 2 Yr. CAGR %	45.44	-6.52	-9.05	49.76	66.11
Inventory, 2 Yr. CAGR %	13.16	-47.34	152.63	94.91	-70.9
Net Property, Plant and Equip., 2 Yr. CAGR %	-4.35	-4.04	-2.6	-4.3	-1.22
Total Assets, 2 Yr. CAGR %	4.87	8.4	6.25	4.91	2.3
Tangible Book Value, 2 Yr. CAGR %	19.3	30.37	13.21	8.1	2.5
Common Equity, 2 Yr. CAGR %	19.3	30.37	13.21	8.1	2.5
Cash From Operations, 2 Yr. CAGR %	24.6	89.72	-18.2	-32.24	-7.09
Capital Expenditures, 2 Yr. CAGR %	-70.15	12.64	47.82	-21.26	40.21
Levered Free Cash Flow, 2 Yr. CAGR %	-26.88	163.57	-36.03	-38.97	-46.91
Unlevered Free Cash Flow, 2 Yr. CAGR %	-23.55	336.76	-38.01	-39.17	-46.91
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	36.24	14.57	23.72	5.87	0.98
Gross Profit, 3 Yr. CAGR %	34.41	12.36	23.36	5.17	0.5
EBITDA, 3 Yr. CAGR %	76.48	33.49	38.9	-7.19	-22.69
EBITA, 3 Yr. CAGR %	13.62	50.89	821.7	-12.38	-42.09
EBIT, 3 Yr. CAGR %	13.62	50.89	821.7	-12.38	-42.09
Earnings From Cont. Operations, 3 Yr. CAGR %	92.13	2.44	89.73	-36.74	-54.77
Net Income, 3 Yr. CAGR %	92.13	2.44	89.73	-36.74	-54.77
Normalized Net Income, 3 Yr. CAGR %	15.38	49.84	94.79	-3.78	-33.01
Diluted EPS Before Extra, 3 Yr. CAGR %	92.06	2.44	89.44	-36.72	-54.4
Accounts Receivable, 3 Yr. CAGR %	16.57	21.41	-5.11	23.8	39.21
Inventory, 3 Yr. CAGR %	-40.09	-38.98	115.25	-12.32	44.96
Net Property, Plant and Equip., 3 Yr. CAGR %	5.83	-3.3	-4.03	-3.26	-2.16
Total Assets, 3 Yr. CAGR %	3.61	5.64	7.35	5.68	3.29
Tangible Book Value, 3 Yr. CAGR %	22	18.35	23.21	10.82	4.96
Common Equity, 3 Yr. CAGR %	22	18.35	23.21	10.82	4.96
Cash From Operations, 3 Yr. CAGR %	7.95	22	27.23	-18.72	-20.96
Capital Expenditures, 3 Yr. CAGR %	-52.46	-34.07	-4.83	25.86	10.12
Levered Free Cash Flow, 3 Yr. CAGR %	-25.42	-21.38	46.26	-30.31	-49.65
Unlevered Free Cash Flow, 3 Yr. CAGR %	-23.77	-20.53	104.36	-31.76	-49.76
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	70.99	28.48	23.09	8.55	15.62
Gross Profit, 5 Yr. CAGR %	119.6	28.38	22.32	6.46	15.31
EBITDA, 5 Yr. CAGR %	11.54	22.27	39.57	9.78	8.9
EBITA, 5 Yr. CAGR %	-5.15	3.9	6.41	12.25	191.92
EBIT, 5 Yr. CAGR %	-5.15	3.9	6.41	12.25	191.92
Earnings From Cont. Operations, 5 Yr. CAGR %	2.22	-0.45	21.56	-12.23	-2.47
Net Income, 5 Yr. CAGR %	2.22	-0.45	21.56	-12.23	-2.47
Normalized Net Income, 5 Yr. CAGR %	-14.66	3.1	11.72	15.31	23.59
Diluted EPS Before Extra, 5 Yr. CAGR %	-8.86	-3.26	21.56	-12.23	-2.09
Accounts Receivable, 5 Yr. CAGR %	413.52	111.3	5.55	32.04	18.71
Inventory, 5 Yr. CAGR %	-32.76	-51.62	6.53	-2.9	-3.32
Net Property, Plant and Equip., 5 Yr. CAGR %	8.74	8.52	2.37	-3.7	-2.92
Total Assets, 5 Yr. CAGR %	13.14	4.3	4.66	5.35	5.3
Tangible Book Value, 5 Yr. CAGR %	1.4	14.38	18.41	14.14	14.46
Common Equity, 5 Yr. CAGR %	1.4	14.38	18.41	14.14	14.46
Cash From Operations, 5 Yr. CAGR %	60.93	4.92	-3.38	-3.57	12.19
Capital Expenditures, 5 Yr. CAGR %	22.31	10.26	-25.16	-29.22	11.12
Levered Free Cash Flow, 5 Yr. CAGR %	20.04	-17.67	-29.86	-28.95	-2.38
Unlevered Free Cash Flow, 5 Yr. CAGR %	380.82	-16.64	-29.82	-28.59	19.32